DRUG-RESISTANT ARTERIAL HYPERTENSION: CLINICAL CAUSES AND MODERN APPROACHES TO INDIVIDUALIZED TREATMENT STRATEGIES

Authors
  • Kasimova Nixola Kadirovna

    Andijan State Medical Institute, Uzbekistan

    Author

Keywords:
Arterial hypertension, resistant hypertension, antihypertensive therapy, personalized medicine, cardiovascular risk.
Abstract

Arterial hypertension remains one of the most prevalent cardiovascular disorders worldwide and a leading risk factor for morbidity and mortality. Despite the availability of multiple antihypertensive agents, a significant proportion of patients fail to achieve optimal blood pressure control, resulting in resistant hypertension. This condition poses serious clinical challenges and increases the risk of cardiovascular complications such as stroke, myocardial infarction, and heart failure. The present article aims to analyze the clinical causes of drug resistance in arterial hypertension and to evaluate modern individualized treatment strategies. Emphasis is placed on pathophysiological mechanisms, patient-related factors, and contemporary personalized therapeutic approaches that improve blood pressure control and clinical outcomes.

References

1.Forouzanfar MH, Liu P, Roth GA, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA. 2017;317(2):165–182. doi:10.1001/jama.2016.19043.

2.Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–967.

3.Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control. Circulation. 2016;134(6):441–450.

4.Carey RM, Calhoun DA, Bakris GL, et al. Resistant hypertension: detection, evaluation, and management. Hypertension. 2018;72(5):e53–e90.

5.Daugherty SL, Powers JD, Magid DJ, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125(13):1635–1642.

6.Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104.

7.Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. Hypertension. 2008;51(6):1403–1419.

8.Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127–e248.

9.Grassi G, Mark A, Esler M. The sympathetic nervous system alterations in human hypertension. Circ Res. 2015;116(6):976–990.

Downloads
Published
2026-02-26
Section
Articles
License
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

DRUG-RESISTANT ARTERIAL HYPERTENSION: CLINICAL CAUSES AND MODERN APPROACHES TO INDIVIDUALIZED TREATMENT STRATEGIES. (2026). Eureka Journal of Health Sciences & Medical Innovation, 2(2), 452-458. https://eurekaoa.com/index.php/5/article/view/529